LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

Search

Revvity Inc

Closed

SectorHealthcare

87.8 2.85

Overview

Share price change

24h

Current

Min

85.34

Max

88.19

Key metrics

By Trading Economics

Income

14M

55M

Sales

56M

720M

P/E

Sector Avg

36.522

35.293

EPS

1.18

Dividend yield

0.34

Profit margin

7.667

Employees

11,000

EBITDA

22M

194M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+31.06% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.34%

3.07%

Next Earnings

3 lis 2025

Next Dividend date

7 lis 2025

Next Ex Dividend date

17 paź 2025

Market Stats

By TradingEconomics

Market Cap

-943M

9.8B

Previous open

84.95

Previous close

87.8

News Sentiment

By Acuity

33%

67%

55 / 371 Ranking in Healthcare

Revvity Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

18 wrz 2025, 23:56 UTC

Hot Stocks

Stocks to Watch: FedEx, 22nd Century, Scholastic

18 wrz 2025, 22:01 UTC

Major Market Movers

22nd Century Group Shares Gain on Debt Repayment, New Capital

18 wrz 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

UPS Terminates Plan to Buy Estafeta

18 wrz 2025, 20:31 UTC

Earnings

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping -- Update

18 wrz 2025, 20:26 UTC

Earnings

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping

18 wrz 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 wrz 2025, 23:43 UTC

Market Talk

Nikkei May Rise on U.S. Stock Gains, Weaker Yen -- Market Talk

18 wrz 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18 wrz 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Cautious Mood -- Market Talk

18 wrz 2025, 23:31 UTC

Market Talk

FedEx Says U.S. Demand Is Resilient -- Market Talk

18 wrz 2025, 22:03 UTC

Earnings

FedEx Expects Trade Environment to Create $1B Headwind in 2026, CFO Says

18 wrz 2025, 22:01 UTC

Earnings

FedEx CFO: Asia-to-U.S. Declines Drove $150M International Export Headwind

18 wrz 2025, 21:56 UTC

Earnings

Lennar Missed Revenue Estimates. The Stock Is Down. -- Barrons.com

18 wrz 2025, 21:54 UTC

Earnings

FedEx Focused on Demand From Southeast Asia, Europe Amid China Shipping Slowdown, Customer Chief Says

18 wrz 2025, 21:48 UTC

Earnings

FedEx International Export Volumes Declined, Especially on China-to-U.S. Lane, Exec Says

18 wrz 2025, 21:47 UTC

Earnings

FedEx Had 5% Increase in U.S. Domestic Average Daily Package Volume in 1Q, Customer Chief Says

18 wrz 2025, 21:17 UTC

Earnings

FedEx Profit, Sales Rise on Improvement in U.S. Shipping -- 2nd Update

18 wrz 2025, 21:07 UTC

Earnings

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18 wrz 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 wrz 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 wrz 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

18 wrz 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

18 wrz 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

UPS Cites Inability of All Closing Conditions to Be Satisfied

18 wrz 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

United Parcel Service Terminates Plan to Buy Estafeta

18 wrz 2025, 20:20 UTC

Acquisitions, Mergers, Takeovers

Here's How Much the U.S. Has Made on Its Intel Stock Purchase -- Barrons.com

18 wrz 2025, 20:18 UTC

Earnings

Nucor Stock Falls After Earnings. Why Its Guidance Was Far Off Rival Steel Dynamics. -- Barrons.com

18 wrz 2025, 20:18 UTC

Earnings

Bullish Crushes Earnings. The Crypto Stock Pops. -- Barrons.com

18 wrz 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18 wrz 2025, 20:07 UTC

Earnings

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18 wrz 2025, 20:03 UTC

Earnings

FedEx 1Q FedEx Freight Segment Revenue $2.26B >FDX

Peer Comparison

Price change

Revvity Inc Forecast

Price Target

By TipRanks

31.06% upside

12 Months Forecast

Average 111.77 USD  31.06%

High 129 USD

Low 93 USD

Based on 13 Wall Street analysts offering 12 month price targets forRevvity Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

8

Buy

5

Hold

0

Sell

Sentiment

By Acuity

55 / 371 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat